HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Gastroenterology
Cohort
Review examines IL-33/ST2 signaling role in MASLD pathophysiology and potential clinical utility
Could a single protein be the key to understanding fatty liver disease?
A review synthesizes evidence primarily from animal models on the interleukin-33 (IL-33)/ST2 signaling pathway in metabolic dysfunction-asso…
A key protein changes levels as fatty liver disease worsens, offering a potential early warning sign and future treatment target for patient…
Frontiers
Apr 3, 2026
Neurology
Sys. Review
Review explores L-carnitine mechanisms for MASLD, a condition affecting over one-third globally
Review explores how supplement L-carnitine might help with common fatty liver disease
A systematic review article summarizes the global burden of MASLD and the proposed mechanisms of L-carnitine. The supplement is theorized to…
L-carnitine might help fatty liver disease by improving how the liver burns fat and reducing inflammation, though human trials are still nee…
Frontiers
Apr 2, 2026
Gastroenterology
Meta-analysis
Meta-analysis links ultra-processed food consumption to increased MASLD risk in 1.2 million participants
Do ultra-processed foods raise your risk of fatty liver disease?
A meta-analysis of 7 prospective cohort studies with 1,272,317 participants found higher ultra-processed food consumption was associated wit…
Eating more ultra-processed foods like sugary drinks and ready meals raises your long-term risk of developing fatty liver disease, a conditi…
Apr 2, 2026